Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 23.6.19941 Min. Lesezeit
Clay-Park Labs, Inc.; Withdrawal of Approval of Three Abbreviated Applications
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is withdrawing approval of one abbreviated antibiotic drug application (AADA) and two abbreviated new drug applications (ANDA's) held by Clay-Park Labs, Inc., 1700 Bathgate Ave., Bathgate Industrial Park, Bronx, NY 10457 (Clay-Park). FDA is withdrawing approval of these applications because of questions raised about the reliability of the data and information submitted to FDA in support of the applications. Clay-Park requested this withdrawal and in so doing has waived its opportunity for a hearing.
Originalsprache der Quelle: Federal Register — Health and Human ServicesOriginalquelle öffnen →